CLINICAL_TRIALS
trial_result
· 2021-07-20
Clinical Trial Update: A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients [Phase 2]
Summary
Phase 2 trial assessing safety and efficacy of ZPL389 with TCS/TCI in atopic dermatitis; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 2 | Status: TERMINATED | Results posted: 2021-07-20